INCREASED COST BURDEN ON PATIENTS OF MENTAL DISORDERS CORRELATED WITH POOR MEDICATION ADHERENCE: A CROSS-SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL IN NORTH INDIA DURING COVID-19 PANDEMIC

ASHISH KUMAR; SUMITA HALDER; SHRUTI SRIVASTAVA; RACHNA GUPTA

doi:10.22159/ijcpr.2024v16i6.5079

Authors

ASHISH KUMAR Department of Pharmacology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi-110095, India
SUMITA HALDER Department of Pharmacology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi-110095, India
SHRUTI SRIVASTAVA Department of Psychiatry, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi-110095, India
RACHNA GUPTA Department of Pharmacology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi-110095, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i6.5079

Keywords:

COVID-19, Drug utilization, Medication adherence

Abstract

Objective: This study was planned to evaluate the correlation between cost borne by the patient and medication adherence in common mental disorder patients during COVID-19 pandemic.

Methods: A descriptive cross-sectional drug utilization study was undertaken in 200 patients. Pattern of psychotropic drugs usage was analyzed as per WHO/INRUD guidelines and average monthly cost borne by the patient/hospital per prescription was correlated with medication adherence of the patients.

Results: The average monthly costs borne by patients and hospital were observed to be more during the pandemic as compared to pre-pandemic time. It was observed that patients bearing some cost on their own had significantly lower medication adherence compared to those patients whose cost of treatment was borne by the government-funded hospital (p-value of 0.017). The medication adherence in patients of mental disorders was found to be negatively correlated to the cost was borne by the patients.

Conclusion: The COVID-19 pandemic has escalated the total cost borne by the patients as well as the financial burden on government-funded hospitals.

Downloads

Download data is not yet available.

References

Shuja KH, Aqeel M, Jaffar A, Ahmed A. COVID-19 pandemic and impending global mental health implications. Psychiatr Danub. 2020;32(1):32-5. doi: 10.24869/psyd.2020.32, PMID 32303027.

Richards F, Kodjamanova P, Chen X, LI N, Atanasov P, Bennetts L. Economic burden of COVID-19: a systematic review. Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307. doi: 10.2147/CEOR.S338225, PMID 35509962.

Sacristan JA, Soto J. Drug utilisation studies as tools in health economics. Pharmacoeconomics. 1994;5(4):299-312. doi: 10.2165/00019053-199405040-00005, PMID 10147239.

Sarangi SC, Kaur N, Tripathi M, Gupta YK. Cost analysis study of neuropsychiatric drugs: role of national list of essential medicines India. Neurol India. 2018;66(5):1427-33. doi: 10.4103/0028-3886.241345, PMID 30233018.

Stirratt MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA. Advancing the science and practice of medication adherence. J Gen Intern Med. 2018;33(2):216-22. doi: 10.1007/s11606-017-4198-4, PMID 29204969.

Niu J, Chen H, Chen K, Liu Y, JU F, Xue T. Effect of pharmaceutical care on the treatment of COVID-19: a protocol for systematic review and meta-analysis. Med (Baltim). 2020;99(48):e23377. doi: 10.1097/MD.0000000000023377, PMID 33235111.

California risk estimator for suicide. Psychology Resource Centre. Available from: https://psycentre.apps01.yorku.ca/wp/california-risk-estimator-for-suicide/. [Last accessed on 24 Nov 2022].

WHO. Inrud drug prescribing indicators at primary health care centres in Eastern province Saudi Arabia. Available from: https://apps.who.int/iris/handle/10665/118483. [Last accessed on 24 Nov 2024].

National list of essential medicines (NLEM); 2015. https://www.nppaindia.nic.in/wp-content/uploads/2020/08/NLEM-2015.pdf. [Last accessed on 28 Nov 2022].

Passi. Drug index. Vol. 22. Passi Publications; 2021. https://www.org/indexes.html. [Last accessed on 30 Nov 2022].

Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020 Jun 23;9:636. doi: 10.12688/f1000research.24457.1, PMID 33093946.

Varma P, Junge M, Meaklim H, Jackson ML. Younger people are more vulnerable to stress anxiety and depression during COVID-19 pandemic: a global cross-sectional survey. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110236. doi: 10.1016/j.pnpbp.2020.110236, PMID 33373680.

Atif M, Azeem M, Sarwar MR, Shahid S, Javaid S, Ikram H. WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the accident and Emergency Department of Bahawal Victoria Hospital Pakistan. Springerplus. 2016;5(1):1928. doi: 10.1186/s40064-016-3615-1, PMID 27933228.

Galappatthy P, Ranasinghe P, Liyanage CK, Wijayabandara MS, Mythily S, Jayakody RL. WHO/INRUD core drug use indicators and commonly prescribed medicines: a national survey from Sri Lanka. BMC Pharmacol Toxicol. 2021;22(1):67. doi: 10.1186/s40360-021-00535-5, PMID 34711271.

Jha AK, Aubert RE, Yao J, Tea garden JR, Epstein RS. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff Millwood. 2012;31(8):1836-46. doi: 10.1377/hlthaff.2011.1198.

GU D, Shen C. Cost-related medication nonadherence and cost reduction strategies among elderly cancer survivors with self reported symptoms of depression. Popul Health Manag. 2020 Apr;23(2):132-9. doi: 10.1089/pop.2019.0035, PMID 31287770.

Holbrook AM, Wang M, Lee M, Chen Z, Garcia M, Nguyen L. Cost related medication nonadherence in Canada: a systematic review of prevalence predictors and clinical impact. Syst Rev. 2021;10(1):11. doi: 10.1186/s13643-020-01558-5, PMID 33407875.

Rao TS, Manohar JS, Raman R, Darshan MS, Tandon A, Karthik KN. The prospective 24 w assessment of cost efficacy of and compliance to antidepressant medications in a rural setting (PACECAR) study. Indian J Psychiatry. 2017;59(2):157-63. doi: 10.4103/psychiatry.IndianJPsychiatry_202_17, PMID 28827861.

Jain B, Garg S, Aggarwal P, Bahurupi Y, Singh M, Kumar R. Health budget in light of pandemic: health reforms from mirage to reality. J Family Med Prim Care. 2022;11(1):1-4. doi: 10.4103/jfmpc.jfmpc_740_21, PMID 35309604.